• Return to Headlines

Shares of Arrowhead Pharma Has Risen Above Previous 52-Week High

By David Diaz

Arrowhead Pharma (NASDAQ:ARWR) traded at a new 52-week high today of $16.64. So far today approximately 193,000 shares have been exchanged, as compared to an average 30-day volume of 2.3 million shares.

Arrowhead Pharma (NASDAQ:ARWR) is currently priced 41.7% above its average consensus analyst price target of $9.60. Arrowhead Pharma shares have support at the 50-day moving average (MA) of $11.30 and additional support at the 200-day MA of $6.69.

Over the past year, Arrowhead Pharma has traded in a range of $1.48 to $16.64 and is now at $16.46, 1,012% above that low. Over the past week, the 200-day moving average (MA) has gone up 3.0% while the 50-day MA has advanced 5.4%.

Arrowhead Pharmaceuticals, Inc. operates as a biotechnology company. The Company develops medicines that treat intractable diseases by silencing the genes. Arrowhead Pharmaceuticals offers its services in the United States.

SmarTrend is tracking the current trend status for Arrowhead Pharma and will alert subscribers who have ARWR in their portfolio or watchlist when shares have changed trend direction.

Keywords: 52 week high/lows arrowhead pharma

Ticker(s): ARWR